PREA has significantly improved pediatric drug research and has led to the development of safer and more effective medications for children. The law has also fostered greater collaboration between pharmaceutical companies, regulatory agencies, and pediatricians. As a result, children now have access to medications that are tailored to their specific needs, reducing the risk of adverse reactions and improving treatment outcomes.
